Lastest News


President Chan-Hwi Cho, “We will focus on issues with household drugs, drug dispensers and civic affairs”

President Chan-Hwi Cho of the Korean Pharmaceutical Association held the ‘2017 New Year Press Conference’ the association’s press corps. In regards to the new year’s work plan, President Cho announced “The regulatory...

Multinational pharmas’s series of administrative actions from MFDS

Multinational pharmaceutical companies have received administrative measures from the Ministry of Food and Drug Safety(MFDS) for violating related regulations, such as the Pharmaceutical Affairs Law. UCB Korea receiv...

Government’s support to nurture cosmetic industry within this year

This year, the government’s various supports will be shown on medium and small cosmetics manufacturers to improve their competitiveness on exports. The Ministry of Health and Welfare(Ministry Jin-Yup Jung) held a mee...

Leo Pharma’s Enstiloom acquires approval as psoriasis treatment in Korea

On the 16th, Leo Pharma Korea(President Kasper Kunzel) announced Enstiloom(generic name: calcipotriol/betamethasone dipropionate 50 micrograms/g / 0.643 mg/g), an external aerosol-form-type psoriasis treatment was rec...

Kyowa Hakko Kirin CEO visits to Korea, “It’s time to take off for our goal”

President Nobuo Hanai, CEO of Japanese Kyowa Hakko Kirin, visited Korea on the 10th. It has been a year since his last visit when suggesting ‘2020 Vision’ on December 2015. President Hanai, who proposed directions an...

‘Draft of the Expenditure Report for Economic Benefits’ completed

A draft of the ‘Expenditure Report for Economic Benefits,’ which will play a key role in exposing rebates, was completed and delivered to related associations and organization. The Ministry of Health and Welfare(MOHW...

MFDS about to join in EU White List after PIC/S & ICH

It was observed the Ministry of Food and Drug Safety(MFDS) is about to join in the EU ‘White List’ after PIC/S and ICH. The MFDS announced the ministry has continuously worked on joining in international organization...

Campaign to block misuse of drug sold outside of pharmacies

The Society for the Future of Pharmacists(President Jin-Hyung Lim) will conduct a national campaign to oppose to expansion of emergency household products sold in video drug dispensers and convenient stores on January...

492 cosmetics manufacturers moved into 117 industrial complexes across the nation

According to the analysis result of registration of cosmetics manufacturing factories in industrial complexes located across the nation as of November 2016, 492 companies are moved into 117 complexes. A complex which...

41% of pet owners visit animal pharmacies because of ‘close distance’ and ‘cheap price’

It was surveyed the reason why people who raise animal companions, like dogs and cats, is because ‘they are able to purchase animal drugs at a close store for inexpensive price.’ The Korea Veterinary Pharmacy Associa...

Kyeong-Ho Lee announces resignation from KPMA Chairman

Chairman Kyeong-Ho Lee of the Korea Pharmaceutical Manufacturers Association(KPMA) will resign from this position a regular general meeting on the coming February. Chairman Kyeong-Ho Lee announced the resignation at ...

What will be changed after resignation of Chairman Kyeong-Ho Lee

Leaving a year left for his term of office, Chairman Kyeong-Ho Lee of the Korea Pharmaceutical Manufacturers Association(KPMA) announced resignation on the 12th, which attracted attention of the industry over the asso...

Opinion differences between prosecution and Novartis at rebate trial

Acceptance or denial of the Novartis’ case in which the company was charged for a new concept of illegal rebate provision through the mass media and PR agencies has not been dec...

Pfizer Pharmaceuticals Korea’s ‘Caduet Tab 10/20mg’ suspended sales for 45 days

A Pfizer Pharmaceuticals Korea’s combination drug for hypertension and hyperlipidemia, ‘Caduet Tab 10/20mg,’ has taken 45 days of administrative measure to suspend its sales activities. On the 12th, the Ministry of F...

JW Life Science acquires commercialization approval of epilepsy therapy ‘Levetiram’

A new-concept solution, which relieve seizure for epilepsy patients, will be released in Korea. JW Life Science(CEO Sung-Nam Cha) announced on the 12th that it has acquired commercialization approval of ‘Levetiram In...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.